ALXO

ALX Oncology Holdings Inc.

Price

$2.06

return (12m)

131.56%

p/e

-3.32

p/bv

1.97

DIVIDEND YIELD

0.00%

ALXO price

ALX Oncology Holdings

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ALXO

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

2.23%

3 months

3.52%

1 year

131.56%

2 years

-19.84%

5 years

-96.71%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals ALXO

Valuation

P/E

-3.32

Sector -4.38

Industry -4.38

P/BV

1.97

Sector 2.02

Industry 2.02

P/Revenue (PSR)

Sector -4.40

Industry -4.40

EV/EBITDA

-7.96

Sector -263.09

Industry -263.09

EV/EBIT

-7.92

Sector -702.90

Industry -702.90

P/EBITDA

-3.40

Sector -4.39

Industry -4.39

P/EBIT

-3.38

Sector -4.73

Industry -4.73

P/Total Assets

1.67

Sector 1.49

Industry 1.49

P/Net Current Assets

2.26

Sector -11.70

Industry -11.70

P/Working Capital

2.09

Sector -3.19

Industry -3.19

EPS

-0.59

Sector -2.14

Industry -2.14

BVPS

1.00

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

0.00%

Sector 36.74%

Industry 36.74%

EBITDA Margin

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

0.00%

Sector -38.22%

Industry -38.22%

Net Profit Margins

0.00%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-59.39%

Sector -65.14%

Industry -65.14%

ROA

-50.30%

Sector -65.53%

Industry -65.53%

ROIC

-228.94%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

9.71

Sector 2.90

Industry 2.90

Net Debt / EBITDA

7.30

Sector -6.07

Industry -6.07

Net Debt / EBIT

7.27

Sector -8.26

Industry -8.26

Net Debt / Equity

-0.94

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.07

Sector -0.05

Industry -0.05

Equity/Assets

0.85

Sector 0.41

Industry 0.41

Liabilities/Assets

0.15

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

-0.63%

Sector -

Industry -

Fundamentals ALXO

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ALXO ALX Oncology Holdings Inc.	$2.06	131.56%	0.00%	-3.32	1.97	-59.39%	0.00%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ALXO Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT ALX Oncology Holdings

ALX Oncology Holdings Inc.

Average Investor10 user rating

4.0 (3 people)

United States

6 years

Founded: 2020

2020

Time since IPO - 6 years

23

Employees

ALX Oncology Holdings Inc. (United States) is listed on the Nasdaq and has a market capitalization of $268.60 million, with shareholders equity totaling $136.19 million.

The company employs approximately 23 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, ALX Oncology Holdings Inc. reported $- in revenue, generating net income of $-80.89 million.

Key financial metrics include a P/E ratio of -3.32, a price-to-book (P/B) ratio of 1.97, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ALXO.

Market cap

$268.60 million

Net worth

$136.19 million

$136,190,000.00

Assets

$160.82 million

$160,820,000.00

Total Shares Outstanding

136.00 million

136,000,000

Average Daily Trading Volume

$1.47 million

$1,470,465.70

Sector

Health Care

Industry

Biotechnology

ALXO

ALXO revenue and profits

Financial Results ALXO

DRAG THE FRAME TO SEE MORE DATA

ALXO cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of ALX Oncology Holdings (ALXO) today?

A cotação de ALX Oncology Holdings (ALXO) hoje está em US$ 2.06, com uma variação de 131.56% em relação ao último ano. A cotação de ALX Oncology Holdings (ALXO) iniciou o ano negociando na casa dos US$ 1.13 e hoje está em US$ 2.06. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de ALX Oncology Holdings (ALXO) e dados de ações do Ibovespa e mercados internacionais.

Quando ALX Oncology Holdings (ALXO) paga dividendos?

ALX Oncology Holdings (ALXO) não distribuiu dividendos no último ano.

Is ALX Oncology Holdings (ALXO) a good investment?

Atualmente, ALX Oncology Holdings (ALXO) está cotada a US$ 2.06, com um P/L de -3.32, representando um desvio de -258% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 131.56 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 131.56%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy ALX Oncology Holdings (ALXO) stock?

Investir em ações de ALX Oncology Holdings (ALXO) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of ALX Oncology Holdings (ALXO) yield today?

A rentabilidade de ALX Oncology Holdings (ALXO) foi de 2.23% no último mês, 131.56% no último ano e -96.71% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de ALX Oncology Holdings (ALXO) hoje, o investimento total seria de US$ 206.00, com base na cotação atual de US$ 2.06.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 477.01
Em 5 anos: US$ 6.78
Em 10 anos: US$ 206.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ALXO

ALX Oncology Holdings Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ALXO

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING ALXO WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT ALX Oncology Holdings

ALX Oncology Holdings Inc.

United States

6 years

2020

23

PROFIT X PRICE ALXO

Financial Results ALXO

ALXO cash flow

Asset, Revenue and Profit Growth - ALXO

ALXO balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions